تجاوز إلى المحتوى الرئيسي

بحث

عنوان الدراسة داعم الدراسة حالة الدراسة دواء الدراسة مرحلة الدراسة رقم بروتوكول الدراسة موقع الدراسة
The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma orOcular Hypertension. Allergan Ongoing Bimatoprost SR 3 192024-092 King Khaled Eye Specialist Hospital (Riyadh), King Abdullah Medical City (Makkah)
Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers, An International, Multicenter, Double Blind, Randomized Placebo Controlled Phase 3 trial (ICR-02/ASCOLT) King Fahad Medical City Ongoing Aspirin 3 ICR-02/ASCOLT King Fahad Medical City (Riyadh)
Efficacy and Safety Assessment of NIlotinib in Chronic Myeloid Leukemia (CML) Patients with Suboptimal Response on Imatinib Therapy (NISRI) KAIMRC Ongoing NILOTINIB 4 RC12/052/R King Abdulaziz Medical City NG (Riyadh), King Fahad Specialist Hospital (Dammam)
Middle East Observational Study in Metastatic Soft Tissue Sarcoma: An epidemiological study on the treatment patterns Novartis Ongoing N/A 4 VEG201319 King Faisal Specialist Hospital and Research Center (Riyadh)
A study of the factors predicting radiation exposure to contacts of Saudi patients treated with radioactive iodine (I 131): A preliminary study for patients’ criteria selection for possible high dose I131 therapy on out-patient basis in the future King Abdulaziz City for Science and Technology (KACST) Completed 131 Iodine 4 (version#1) dated 10-Apr-14 King Abdullah Medical City (Makkah)
(FLASH study)A 12-week treatment, multi-center, randomized, doubleblind,double-dummy, parallel group study to assess the efficacy and safety of switching fromsalmeterol/fluticasone to QVA149 (indacaterolmaleate/glycopyrronium bromide) in symptomatic COPD patients Novartis Ongoing Ultibro breezhaler 4 A3405 V01 King Fahad Medical City (Riyadh), King Fahad University Hospital (Al-Khobar), King Abdulaziz Medical City NG (Jeddah)
Prospective, multicentre, international Registry of male and female patients newly diagnosed with Atrial Fibrillation and treated with Rivaroxaban Thrombosis Research Institute Ongoing Rivaroxaban 4 TRI08890 Armed Forces Hospital (Southern Region)
Prospective Multicentre Observational Registry Of Treatments And Outcomes In Patients With Chronic Astellas Pharma International Ongoing N/A 4 ONC-MA1002 Aseer Central Hospital
XALIA LEA- Xarelto® for Long-term and Initial Anticoagulation in VenousThromboembolism (VTE) in Latin America,EMEA and Asia Bayer Ongoing Rivaroxaban 4 17237 King Fahad Medical City (Riyadh), King Fahad Hospital (Madinah), King Faisal Hospital (Taif), Hira Hospital (Makkah)
Efficacy of Different Mouthwashes in the Reduction of Halitosis: A Randomized, Double Blind, Placebo-Controlled, Crossover Clinical Trial King Abdulaziz City for Science and Technology (KACST) Ongoing Halita - AO ProRinse 4 PR oo39 College of Dentistry King Saud University
عرض 351 - 360 من 419